US FDA Cautions Against Blaming CRLs On Inspection Delays
Executive Summary
Agency revises pandemic inspection guidance to explain CRL ‘non-deficiency’ inspection comments and update industry on remote interactive evaluations and post-COVID-19 inspection priorities.